OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility
Limin Zhao, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4906-4917
Open Access | Times Cited: 7
Limin Zhao, Christophe Pannecouque, Erik De Clercq, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 4906-4917
Open Access | Times Cited: 7
Showing 7 citing articles:
DrugFlow: An AI-Driven One-Stop Platform for Innovative Drug Discovery
Chao Shen, Jianfei Song, Chang‐Yu Hsieh, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 14, pp. 5381-5391
Closed Access | Times Cited: 8
Chao Shen, Jianfei Song, Chang‐Yu Hsieh, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 14, pp. 5381-5391
Closed Access | Times Cited: 8
Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to C NNH2-Biphenyl-Diarylpyrimidines
Xiaomei Chen, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117271-117271
Closed Access
Xiaomei Chen, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117271-117271
Closed Access
Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility
J. Wang, Kexin Zhao, Kun Zhang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107340-107340
Closed Access | Times Cited: 4
J. Wang, Kexin Zhao, Kun Zhang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107340-107340
Closed Access | Times Cited: 4
Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer’s disease
Zhipei Sang, Shuheng Huang, Wanying Tan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Zhipei Sang, Shuheng Huang, Wanying Tan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIs
Yanying Sun, Zhenzhen Zhou, Na Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6570-6584
Closed Access | Times Cited: 3
Yanying Sun, Zhenzhen Zhou, Na Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6570-6584
Closed Access | Times Cited: 3
Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 5
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 5
Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation
Zongji Zhuo, Zhao Wang, Lanlan Jing, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9028-9028
Open Access
Zongji Zhuo, Zhao Wang, Lanlan Jing, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9028-9028
Open Access
